Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
In type 2 diabetes mellitus, insulin resistance occurs primarily within the muscles, liver, and fat tissue, leading to decreased glucose uptake and utilization.
There is a relative impairment in insulin secretion by pancreatic β-cells, contributing to hyperglycemia.
Due to insulin resistance, the liver inappropriately releases glucose into the blood, exacerbating hyperglycemia.
Increased breakdown of lipids within fat cells contributes to insulin resistance and β-cell dysfunction.
There is resistance to and lack of incretin effect, hormones that enhance insulin secretion in response to meals.
Elevated glucagon levels in the blood contribute to increased hepatic glucose production.
Increased retention of salt and water by the kidneys can contribute to hypertension in diabetic patients.
Inappropriate regulation of metabolism by the central nervous system may play a role in the development of type 2 diabetes.
Genetic predisposition influences insulin secretion and action, affecting individual susceptibility to diabetes.
Chronic low-grade inflammation contributes to insulin resistance and β-cell dysfunction.
Structural narrowing of small arteries and arterioles leads to increased resistance to blood flow, elevating blood pressure.
Overactivity of the RAAS leads to vasoconstriction and sodium retention, contributing to hypertension.
Enhanced sympathetic tone increases heart rate and vascular resistance, elevating blood pressure.
Impaired endothelium-derived nitric oxide production reduces vasodilation, promoting vasoconstriction.
Kidney dysfunction leads to impaired sodium excretion, increasing blood volume and pressure.
Genetic predisposition affects blood pressure regulation mechanisms, influencing hypertension risk.
Excess adipose tissue elevates blood pressure through mechanisms like increased RAAS activity and sympathetic overactivity.
Common in metabolic syndrome, it contributes to hypertension through sympathetic activation and sodium retention.
Chronic low-grade inflammation contributes to endothelial dysfunction and vascular stiffness, promoting hypertension.
Structural changes in blood vessels, including increased wall thickness, reduce lumen diameter, raising vascular resistance.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.